Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

KIND LED Helps Dad Treat Daughter’s Rare Illness - This Father is Leading the Charge to Change Cannabis Laws in Washington with Ducky’s Bill
  • USA - English


News provided by

KIND LED

Jun 07, 2018, 12:00 ET

Share this article

Share toX

Share this article

Share toX

John and River (Ducky) Barclay
John and River (Ducky) Barclay

SAN FRANCISCO (PRWEB) June 07, 2018 -- John Barclay, a Washington State father and former IT engineer, has found himself doing something he never imagined he’d do: growing and cultivating cannabis. Using a pair of LED grow lights donated by Kind LED, he’s created a makeshift nursery in his garage in order to supply his 8-year old daughter with a reliable source of CBD oil to help treat her seizures.

The first time River tried a CBD tincture, her transformation was immediate. She was able to spend the entire day at school, a massive improvement over where we had come from. I believe her incredible improvements were completely due to CBD oil. In our case it was nothing short of liquid gold.

Post this

In 2014 at the young age of four, John’s daughter River—affectionately known as “Ducky”—was diagnosed with a generalized epileptic disorder. She was suffering from 60-80 Myoclonic seizures every day and weekly Grand Mal seizures, some lasting for several minutes. She quickly began treatment, going through a series of five different medications, but most of them just made River’s seizures even worse.

After being removed from an FDA synthesized CBD trial at Mary Bridge Children’s Hospital in Tacoma, River’s parents decided to utilize the natural form of CBD found in cannabis as the next step in her path to recovery.

“The first time River tried a CBD tincture, her transformation was immediate,” explained Barclay. “She was able to spend the entire day at school, and had fewer than five seizures. This was a massive improvement over where we had come from. I honestly believe her incredible improvements were completely due to CBD oil. In our case it was nothing short of liquid gold.”

Unfortunately, three years after River’s initial diagnosis, things changed. What was initially diagnosed as a generalized epileptic disorder was discovered to be something significantly more serious. River’s seizures were actually an early symptom of an incredibly rare pediatric brain disorder called CLN2—a disease in the Batten group of pediatric brain disorders. CLN2 affects the nervous system and typically causes problems with vision, movement, and cognition. It is incredibly rare—only an estimated 20 children per year are born with the disorder in the United States, and it’s estimated that approximately 350 American children currently have the disease. Sadly, CLN2 is a terminal disorder, and most children diagnosed with the disease do not live past the age of 10.

With this new diagnosis, John’s focus has turned to providing Ducky with the absolute best quality of life possible. But as Barclay began treating his daughter’s seizures with CBD oil, he quickly learned that his daughter responded better to certain strains than others, and finding a reliable source of the oil that best helped his daughter was a challenge. He decided to take matters into his own hands, and started to grow cannabis so that he could create his own oil. While setting up the nursery in his garage, Barclay reached out to KIND LED.

“My background is in engineering and technology, and after a little research I came across KIND LED. They seemed to be the industry leader, and their technology impressed me,” stated Barclay.

“We are humbled that John reached out to us, and more than happy to provide him with whatever he needs to improve River’s quality of life,” said Rory Kagan, CEO of Kind LED Grow Lights. “We are blown away by the Barclay family’s strength and determination, and we want to do anything we can to help them.”

With the help of his new KIND LEDs, Barclay has been able to continually grow strains which have produced high-quality CBD oil, and help River enjoy a quality of life she otherwise wouldn’t be able to. She was even able to start attending school.

This is when the Barclay family met yet another hurdle. River’s school, like all schools in Washington, refuse to allow medical cannabis on school grounds despite the fact that cannabis is legal both medically and recreationally in Washington State. Parents are not allowed to bring or administer cannabis-derived medication to their children, even under the supervision of a school nurse. Therefore, John is unable to administer the CBD oil that has been making such a difference in River’s life, and has had no choice but to remove River from school midway through the day.

As a result, Barclay has made it his quest to change the law with Ducky’s Bill (HB 1060 and SB 5290), which would require school districts in Washington State to allow students who meet the nine criteria required to be a medical marijuana user the ability to consume cannabis on school grounds under the supervision of a parent or guardian, provided it is not smoked or otherwise inhaled. The bill has received bipartisan support, sponsored by Brian Blake (D-Aberdeen) and James Walsh (R-Aberdeen), and is currently making its way through the legislature.

Ducky’s Bill would help more than 50 children in Washington State, who are currently reliant upon medical marijuana and unable to attend school, get a proper education, socialize with other children, and lead more normal lives.

For more information about John and River Barclay, please visit https://www.kindledgrowlights.com/blogs/news/john-and-river-barclay and contact Washington state officials to show your support for Ducky’s bill.

Available online at https://kindledgrowlights.com, and through hundreds of retailers nationwide, KIND LED makes advanced horticulture lighting technology accessible to both professional and recreational growers worldwide.

About KIND LED Grow Lights.
San Francisco based KIND LED Grow Lights is the industry leader for indoor LED grow lights offering cutting-edge LED indoor grow light technology. Revolutionizing the indoor growing industry and founded by age old growers, KIND LED Grow Lights provide the most rewarding results possible for hydroponic and indoor gardens. Quickly becoming the world’s top selling grow light, KIND LED received the S.T.A.S.H “Gear of the Year” award in 2014, 2015, 2016 and 2017. For more information or to purchase KIND LED Grow Lights products, please visit https://www.kindledgrowlights.com or search for #KINDLED on social media.

Matthew Price, KIND LED, https://kindledgrowlights.com, +1 877.476.9787, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.